Aegis Capital Downgrades Kindred Biosciences to Hold, Lowers Price Target to $9.25
Aegis Capital analyst Nathan Weinstein downgrades Kindred Biosciences (NASDAQ:KIN) from Buy to Hold and lowers the price target from $16 to $9.25.
Why Chinese Education Stocks Are Trading Lower Today
Shares of several Chinese education stocks are trading lower following reports suggesting China will impose tougher restrictions on the private tutoring industry, including bans on vacation tutoring.
Analysts from Morgan Stanley also downgraded the Chinese education stocks.
B of A Securities Downgrades ResMed to Underperform, Raises Price Target to $221
B of A Securities analyst Lyanne Harrison downgrades ResMed (NYSE:RMD) from Neutral to Underperform and raises the price target from $216 to $221.
Morgan Stanley Downgrades New Oriental Education to Equal-Weight, Announces $8.6 Price Target
Morgan Stanley analyst Sheng Zhong downgrades New Oriental Education (NYSE: EDU) from Overweight to Equal-Weight and announces $8.6 price target.Morgan Stanley analyst Sheng Zhong downgrades New Oriental Education (NYSE:EDU) from Overweight to Equal-Weight
Citigroup Downgrades Sage Therapeutics to Neutral, Lowers Price Target to $68
Citigroup analyst Neena Bitritto-Garg downgrades Sage Therapeutics (NASDAQ:SAGE) from Buy to Neutral and lowers the price target from $101 to $68.
Redburn Partners Downgrades BioNTech to Sell
Redburn Partners analyst Simon Baker downgrades BioNTech (NASDAQ:BNTX) from Neutral to Sell.
JP Morgan Downgrades Insight Enterprises to Neutral, Announces $106 Price Target
JP Morgan analyst Paul Coster downgrades Insight Enterprises (NASDAQ:NSIT) from Overweight to Neutral and announces $106 price target.
Stifel Downgrades Kinder Morgan to Hold, Announces $18 Price Target
Stifel analyst Selman Akyol downgrades Kinder Morgan (NYSE:KMI) from Buy to Hold and announces $18 price target.
Goldman Sachs Downgrades Ameren to Neutral, Announces $90 Price Target
Goldman Sachs analyst Insoo Kim downgrades Ameren (NYSE:AEE) from Buy to Neutral and announces $90 price target.